BOSTON, May 28, 2025 -- Aktis Oncology, Inc., an oncology company focused on unlocking the breakthrough potential of targeted radiopharmaceuticals for patient populations not addressed by existing platform technologies, today announced...
Borah was formed in 2022 when the company Boragen was split into three separate companies, 5Metis, Borah and Reactive Biosciences.
© 2025 Pappas Capital, LLC. ALL RIGHTS RESERVED.